The Promising Company OSE Pharma launches an IPO
Created in 2012 by Emile Loria and Dominique Costantini, OSE Pharma is a European cancer…
March 10, 2015 - 3 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
MorphoSys and Emergent BioSolutions Initiate Phase I
MorphoSys AG and Emergent BioSolutions will initiate a Phase I clinical study to evaluate the…
March 9, 2015 - 3 minutes
Novartis announces completion of transactions with GSK
Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint…
March 5, 2015 - 5 minutes
Bristol-Myers Squibb signs an agreement for Bavarian Nordic’s PROSTVAC
Bristol-Myers Squibb signs an exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer…
March 4, 2015 - 2 minutes
Highway to Brain
Researchers in Barcelona have developed a shuttle to transport drugs into the brain, running through the…
February 18, 2015 - 2 minutes
Italian Genenta Science’s Original Strategy to Treat Cancer
Tumor microenvironment, including tumor-associated macrophages, plays a key role in controlling tumor progression and response…
January 27, 2015 - 2 minutes
Nanobiotix on its way to change the paradigm in cancer therapy
Nanobiotix is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Their NanoXray technology…
January 8, 2015 - 4 minutes
An Effective Renewed Partnership for Treatment of Gynecological Cancers
Curie-Cancer, the part responsible for developing Institut Curie’s industry partnership activities, and GamaMabs Pharma, a company specialized in…
December 16, 2014 - 2 minutes
After Merck’s Big Deal, Pfizer Collaborates with iTeos Therapeutics for Cancer Treatments
iTeos Therapeutics SA enters in a strategic collaboration with Pfizer Inc where iTeos will license to…
December 11, 2014 - 2 minutes
An Orphan Drug Status Granted for the Leading Telormedix’s Cancer Treatment
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer…
December 8, 2014 - 2 minutes
New Treatment against critic Leukemia Approved In Europe
Janssen's Imbruvica (ibrutinib), the once-daily oral Bruton's tyrosine kinase (BTK) inhibitor, has been approved in Europe…
October 22, 2014 - 2 minutes
European’s First Personalized Vaccines to Treat Brain Cancer
A novel concept of fully personalized therapeutic cancer vaccines, called Glioma Actively Personalized VAccine Consortium…
October 20, 2014 - 3 minutes
